Esophageal cancer phospholipids correlated with histopathologic findings: A 31P NMR study

NMR in Biomedicine

Volumn 12, Issue 4, 1999, Pages 184-188

  Merchant, Thomas E ^a,d   Minsky, Bruce D ^a   Lauwers, Gregory Y ^b   Diamantis, Pamela M ^b   Haida, Toni ^a   Glonek, Thomas ^c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c MIDWESTERN UNIVERSITY   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

31P NMR; Cancer; Esophagus; Neoplasms; NMR; Phospholipids

Indexed keywords

LYSOETHANOLAMINE; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; N,N DIMETHYLPHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; PHOSPHORUS 31; PLASMALOGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER STAGING; CORRELATION FUNCTION; ESOPHAGUS CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; LYMPHATIC SYSTEM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ESOPHAGEAL NEOPLASMS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOLIPIDS;

EID: 0032811433     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199906)12:4<184::AID-NBM560>3.0.CO;2-M     Document Type: Article

References (45)

1. Merchant, T. E., Graaf, P. W., Minsky, B. D., Obertop, H. and Glonek, T. Esophageal cancer phospholipid characterization by 31P NMR. NMR Biomed. 6, 187-193 (1993).
2. Merchant, T. E., Magnetic resonance spectroscopy of the breast. In: Breast Imaging. P. Davis, ed. MRI Clinics of North America Vol. 2, pp. 691-703 (1994).
3. Merchant, T. E., Thelissen, G. R. P., de Graaf, P. W., Den Otter, W. and Glonek, T. Clinical magnetic resonance spectroscopy of human breast disease. Invest. Radiol. 26, 1053-1059 (1991).
4. Twelves, C. J., Porter, D. A., Lowry, M., Dobbs, N. A., Graves, P. E., Smith, M. A., Rubens, R. D. and Richards, M.A. Phosphorus-31 metabolism of post-menopausal breast cancer studied in vivo by magnetic resonance spectroscopy. Br. J. Cancer 69, 1151-1156 (1994).
5. 31P magnetic resonance spectroscopic profiles of neoplastic human breast tissues. Cancer Res. 48, 5112-5118 (1988).
6. 31P magnetic resonance phospholipid profiles of neoplastic human breast tissues. Br. J. Cancer 63, 693-698 (1991).
7. Ting, Y. L., Sherr, D. and Degani, H. Variations in energy and phospholipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res. 16, 1381-1388 (1996).
8. Gribbestad, I. S., Petersen, S. B., Fjosne, H. E., Kvinnsland, S. and Krane, J. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed. 7, 181-194 (1994).
9. Speckter, H., Blumich, B., Just, M., Tromel, U., Mitze, M. and Thelen, M. In vitro NMR spectroscopy of healthy, pathologically changed and carcinomatous breast tissue samples correlated with histologic findings. ROFO 161, 147-153 (1994).
10. 31P NMR of phospholipid glycerol phosphoryldiester residues. J. Lipid Res. 31, 479-486 (1990).
11. Su, B., Kappler, F., Szwergold, B. S. and Brown, T. R. Identification of a putative tumor marker in breast and colon cancer. Cancer Res. 53, 1751-4 (1993).
12. Carlsen, S. A., Xie, Y., Whitfield, D. M., Pang, H. and Krepinsky, J. J. Isoglobotetraosylceramide is a marker for highly metastatic cells in rat mammary adenocarcinomas. Cancer Res. 53, 2906-11 (1993).
13. Taylor, J. S., Langston, J. W., Reddick, W. E., Kngsley, P. B., Ogg, R. J., Pui, M. H., Kun, L. E., Jenkins, J. J. 3rd, Chen, G., Ochs, J. J., Sanford, R. A. and Heideman, R. L. Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int. J. Radiat. Oncol. Biol. Phys. 36, 1251-1261 (1996).
14. 31P NMR profiling of phospholipids. In: Advances in Lipid Methodology, ed. WW Christie, vol 3, The Oily Press, West Ferry, Dundee, Scotland, (1995).
15. Guy, G. R., Philip, R. and Tan, Y. H. Analysis of cellular phosphoproteins by two-dimensional gel electrophoresis: applications for cell signaling in normal and cancer cells. Electrophoresis 15, 417-440 (1994).
16. Hamaguchi, M., Matsuyoshi, N., Ohnishi, Y., Gotoh, B., Takeichi, M. and Nagai, Y. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J. 12, 307-314 (1993).
17. Gawler, D. J., Zhang, L. J., Reedijk, M., Tung, P. S. and Moran, M. F. CaLB: a 43 amino acid calcium-dependent membrane/phospholipid binding domain in p120 Ras GTPase-activating protein. Oncogene 10, 817-825 (1995).
18. Borek, C. Omega 3 fatty acids as anticarcinogens: cellular and molecular studies. World Rev. Nutr. Dietetics 76, 66-69 (1994).
19. Zhou, W., Parent, L. J., Wills, J. W. and Resh MD. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68, 2556-2569 (1994).
20. Beech, J. A. The membrane cluster hypothesis of mitogenesis and carcinogenesis. Med. Hypoth. 41, 165-172 (1993).
21. 31P NMR characterization of cellular metabolism during dexamethasone induced apoptosis in human leukemic cell lines. J. Cell. Physiol. 158, 180-186 (1994).
22. Eds: Beahrs O. H., Henson D. E., Hutter R. V. P., Kennedy B. J., Manual for staging of cancer., 4th edition, pp. 56-61. J. B. Lippincott, Philadelphia, PA (1992).
23. 31P NMR of extracted phospholipids. J. Lipid Res. 29, 679-689 (1988).
24. 31P NMR of tissue phospholipids: a comparison of three tissue pre-treatment procedures. J. Lipid Res. 30, 458-461 (1989).
25. Folch J., Lees M. and Sloan-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226, 497-509 (1957).
26. 31P NMR: comparing isopropanol pretreatment with simple chloroform/methanol extraction. Int. J. Biochem. 25: 903-910.
27. 31P NMR in the analysis of extracted tissue phospholipids. In: Quin L. D., Verkade J. G. (eds) P-31 NMR Spectral Properties in Compound Characterization and Structural Analysis. VCH, New York, pp. 283-294.
28. Sachedina S., Greiner J. V. and Glonek T. (1991), Membrane phospholipids of the ocular tunica fibrosa. Invest. Ophthal. Visual Sci. 32: 625-632.
29. Diehl B. E. K. and Ockels W. (1995) Quantitative analysis of lecithin: phospholipid analysis with P-NMR-spectroscopy. In: Cevc G, Paltauf F (eds). Phospholipids: Characterization, Metabolism, and Novel Biological Applications. AOCS Press, Champaign, IL, pp. 29-32.
30. 31P NMR at different compositions of the solvent system chloroform-methanol-water. Magn. Reson. Med. 26: 46-59.
31. Bárány M. and Glonek T. (1982) Phosphorus-31 nuclear magnetic resonance of contractile systems. In: Frederiksen D. L., Cunninghan L. W. (eds). Methods in Enzymology, Vol. 85B, Academic Press, New York, pp. 624-676.
32. Burt T. C., Glonek T. and Bárány M., (1976), Analysis of phosphate metabolites, the intracellular pH, and the state of adenosine triphosphate in the intact muscle by phosphorus nuclear magnetic resonance. J. Biol. Chem. 251: 2584-2591.
33. Klunk, W. E., Xu, C. J., Panchalingam, K., McClure, R. J. and Pettegrew, J. W. Analysis of magnetic resonance spectra by mole percent: comparison to absolute units. Neurobiol. Aging 15, 133-140 (1994).
34. 31P NMR phospholipid analysis of anionic-enriched lecithins. J. Am. Oil Chem. Soc. 75, 569-573 (1998).
35. Norusis, M. J., SPSS for Windows: Base System User's Guide: Release 6.0. Chicago, IL: SPSS, 1993.
36. DeRosa, J., Marcinkiewicz, M., Sarosiek, J., Edmunds, M. and McCallum, R. W. Modulatory impact of acid and pepsin on esophageal hydrophobicity in humans. Am. J. Gastroenterol. 90, 2020-2024 (1995).
37. Hills, B. A. Oesophageal surfactant: evidence for a possible mucosal barrier on oesophageal epithelium. Aust. NZ J. Med. 24 41-46 (1994).
38. Mattson, K. Normal lung biology. Lung Cancer 10 (Suppl. 1), 53-58 (1994).
39. Scarpelli, E. M., The Surfactant System of the Lung. Leand febiger, Philadelphia, PA (1968).
40. Post, M., Batenburg, J. J., Schuurmans, E. A. J. M., Laros, C. D. and van Golde, L. M. G. Lammellar bodies isolated from adult human lung tissue. Exp. Lung Res. 3, 17-28 (1982).
41. Sadana T., Dhall, K., Sanyl, S. N., Wali, A., Minocha, R. and Majumdar, S. Isolation and chemical composition of surface-active material from human lung lavage. Lipids 23, 551-558 (1988).
42. Mcintosh, T. J. and Magid, A. D., Phospholipid hydration. In: Phospholipids Handbook, ed. G. Ceve, pp. 553-577. Marcel Dekker, New York (1993).
43. Seddon, J.M. and Cevc, G., Lipid polymophism. In: Phospholipids Handbook, ed. G. Cevc. pp. 403-454. Marcel Dekker, New York (1993).
44. Hermetter, A. and Paltauf, F., Ether lipids: biochemical and biomedical aspects. In: Phospholipids: Characterization, Metabolism, and Novel Biological Applications, eds. G. Cevc, F. Paltauf, pp 260-273. AOCS Press, Champaign, IL (1995).
45. Sarbia, M., Bittinger, F., Porschen, R., Dutkowski, P., Willers, R. and Gabbert, H. E. Prognostic value of histopathologic parameters of esophageal squamous cell carcinoma. Cancer 76, 922-927 (1995).